New study tests therapy for caregivers of transplant patients

NCT ID NCT06472089

Recruiting now Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 6-session counseling program called BMT-CARE for caregivers of people receiving a bone marrow transplant. The goal is to see if it improves the caregiver's quality of life compared to standard support. The study will enroll 800 caregivers and also look at what helps or hinders using the program in real hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BMT-CARE (a 6-session therapist-delivered psychosocial intervention)
What this could lead to: If it works, this could provide a proven way to support caregivers and improve their well-being during a loved one's transplant.
What could go wrong: This is a behavioral study, not a drug trial, so the effect may be modest. Results depend on caregiver engagement and may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm neoplasm Neoplasms by Site

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE MARROW TRANSPLANT COMPLICATIONS HEMATOLOGIC MALIGNANCY

Contacts and locations

Locations

Massachusetts General Hospital Cancer Center
RECRUITING

Boston, Massachusetts, 02114, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
University of Alabama at Brimingham
RECRUITING

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.